Biological Nanotherapeutics Derived From Human Umbilical Cord Mesenchymal Stem Cells: Mechanisms and Translational Potential in Multisystem Therapies for Regeneration and Oncology

Oct 13, 2025International journal of nanomedicine

Tiny Therapies from Human Umbilical Cord Stem Cells: How They Work and Their Potential to Treat Multiple Diseases Including Tissue Repair and Cancer

AI simplified

Regenerative Health on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

derived from (hucMSCs-EVs) show promise as a therapeutic strategy in regenerative medicine and oncology.

HucMSCs-EVs exhibit low immunogenicity and are sourced non-invasively.
These vesicles possess multiple regenerative properties, including promoting tissue repair through immunomodulation, angiogenesis, and anti-apoptosis.
HucMSCs-EVs can have varying effects on tumors, acting either pro- or anti-tumor depending on the microenvironment.
Challenges for clinical use include standardizing production, optimizing delivery, and ensuring safety.
Heterogeneity, biodistribution limitations, and environment-dependent efficacy may constrain their universal applicability.

AI simplified

derived from (hucMSCs-EVs) represent a promising cell-free therapeutic strategy in regenerative medicine and oncology. These vesicles exhibit low immunogenicity, are non-invasively sourced, and possess multiple regenerative properties. This review examines the biogenesis of EVs and distinctive features of hucMSCs-EVs compared to other MSC-derived EVs. We explore their molecular mechanisms and preclinical efficacy across multiple organ systems, including nervous, locomotor, respiratory, circulatory, digestive, urinary, reproductive, and hormonal. HucMSCs-EVs demonstrate a dual role: promoting tissue repair through immunomodulation, angiogenesis, and anti-apoptosis in regenerative contexts, while exerting microenvironment-dependent pro- or anti-tumor effects in oncology. Despite promising preclinical results, clinical translation requires overcoming challenges such as standardized production, delivery optimization, and safety evaluation. As multifunctional biological nanotherapeutics, hucMSCs-EVs show transformative potential for treating multisystem diseases. However, their universal applicability is constrained by heterogeneity, biodistribution limitations, and environment-dependent efficacy. Future work should focus on scalable manufacturing, targeted delivery strategies, and rigorous clinical trials to realize their full therapeutic potential.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text (PDF) ↗

Biological Nanotherapeutics Derived From Human Umbilical Cord Mesenchymal Stem Cells: Mechanisms and Translational Potential in Multisystem Therapies for Regeneration and Oncology

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week: